act in Medical Technology

Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009

NEW BRUNSWICK, N.J., May 7 /PRNewswire-FirstCall/ -- In letters to Senate Special Committee on Aging Chairman Herb Kohl (D-WI) and Senate Finance Committee Ranking Member Charles Grassley (R-IA), Johnson & Johnson today announced its support for the Physician Payments Sunshine Act of 2009 (S. ...

Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type Disasters; House Urged to Act on Strong Drug Safety Bill

First significant drug safety measure in 45 years; focus moves to House WASHINGTON, May 09, 2007 /PRNewswire-USNewswire/ -- The Senate today overwhelmingly passed significant prescription drug safety reforms to give the Food and Drug Administration more power to deal with unsafe medicines on the m...

Cardiome And Astellas Announce Positive Results From ACT 2 Trial

NASDAQ: CRME TSX: COM VANCOUVER and DEERFIELD, IL, June 04, 2007 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced results from their recently completed Phase 3 clinical study, called ACT 2. The trial evaluated the e...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

... Forward Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estim...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... In bone metabolism, PTHrP (parathyroid hormone-related protein) and its analogs are critical peptides for promoting new bone formation. Though they act through the same receptor, PTHrP and its analogs play a distinct biological role from the PTH (parathyroid hormone) peptide by activating different si...

Scientists Discover Origin of Malaria

...roader range of close relatives to the human parasite than were previously recognized, some of which might provide key insights in drug development or act as vaccines that could prevent human malaria. "Dr. Wolfe's discovery of the origin of human malaria is a perfect example of the kind of researc...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...www.elandrugtechnologies.com . (This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertain...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

...ccesspharma.com . This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clin...

GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip

...of the highest HIV rates in the world. As a U.S. Senator, Secretary Clinton was a co-sponsor of the International Violence Against Women act (IVAWA) in the last session of Congress, and she is thus well aware that gender-based violence occurs even in countries where there is no current conf...

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

...elopment efforts focus on nucleos(t)ide analogs, a class of compounds which act as alternative substrates for the viral polymerase thus inhibiting viral re...sset "Safe Harbor" Statement under the Private Securities Litigation Reform act of 1995: Statements in this press release regarding our business that are n...

Covance Receives Highest Level of Phase I Accreditation

...ase, which are not historical facts, are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are base...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

...E: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform act of 1995, including statements relating to the clinical development of, the commercial plans for and the potential market for SAPHRIS/SYCREST. Forward...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

...edcohealth.com . This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forwa...

Diabetes Gene Raises Odds of Lower Birth Weight

...that the same gene that causes lower birth weight also increases the risk of developing type 2 diabetes. "The mechanisms by which CDKAL1 may act are not well understood, but it is believed to reduce insulin secretion, and that underproduction contributes to type 2 diabetes," said Grant. He adde...

Cyberonics Provides Update on Depression Post-Approval Study

...ward-looking statements within the meaning of Section 27A of the Securities act of 1933, as amended and Section 21E of the Securities Exchange act of 1934, as amended. These statements can be identified by the use of forw...

NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

...or Qutenza in PHN has a Prescription Drug User Fee act (PDUFA) date of August 16, 2009. In Stud...er 2008 and was given a Prescription Drug User Fee act (PDUFA) date of August 16, 2009. Neurog...rposes of the Private Securities Litigation Reform act of 1995 (the "Act"). NeurogesX disclaims any inten...

Injection Reverses Heart-Attack Damage

...how both periostin and NRG1 work at the cellular and molecular level, an essential step in predicting possible side effects. Both compounds ultimately act on the same cellular pathway, Kuhn found. "We applied periostin locally at the site of cardiac injury, but NRG1 works when given by systemic ...

Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)

...he New Drug Application (NDA) for the fixed-dose combination (FDC) of alogliptin and ACTOS((R)) (pioglitazone HCl). The new Prescription Drug User Fee act (PDUFA) date for the FDC is September 4, 2009. The NDA for the FDC of alogliptin and ACTOS was submitted in September 2008, following the ND...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

...E: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform act of 1995, including statements relating to the potential market for investigational mometasone furoate/formoterol fumarate MDI. Forward-looking stateme...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...ward-looking Statements This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform act of 1995. Such forward-looking statements can be identified by the use of forward-looking terminology such as "expect," "plans," "anticipates," "will,"...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

...thin the safe harbor provisions of the Private Securities Litigation Reform act of 1995 based on current expectations, estimates, forecasts and projections... the U.S. Securities and Exchange Commission into Foreign Corrupt Practices act matters announced in October 2007; price and product competition; changes i...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...ithin the meaning of Section 27A of the Securities act of 1933, as amended, and Section 21E of the Securities Exchange act of 1934, as amended. The forward-looking statement...ons of the US Private Securities Litigation Reform act of 1995, GSK cautions investors that any forward-l...

Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results

...e appetite and energy expenditure, as well as the mechanisms that come into play to limit weight loss over time. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further inform...

Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences

...Forward-Looking Statement This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncerta...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

... www.oncolyticsbiotech.com This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange act of 1934, as amended. Forward-looking statements, including the implication of the materials presented in "Molecular Cancer" with respect to REOLYSIN, ...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

...E: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform act of 1995, including statements relating to the company's clinical development plans and the potential for vicriviroc. Forward-looking statements relat...

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

...or of the Brain Tumor group at Memorial Sloan-Kettering Cancer Center, will act as the study's Principal Investigator. The study announced today is being ...rd-looking statements contained in the Private Securities Litigation Reform act of 1995. Among the factors that could cause our actual results to differ ma...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

...es and other disorders, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the ris...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

...ation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

...orward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995 regarding, among other things, the company's financial position, results of operations, market position, product development and business stra...

ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients

...E: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform act of 1995, including statements relating to potential market for ASMANEX. Forward-looking statements relate to expectations or forecasts of future even...

Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis

....accesspharma.com . This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clin...

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

...tements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform act of 1995. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "co...

Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet

.... Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S. Private Securities Litigation Reform act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject...

5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH

... Forward Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include product development , produ...

Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis

...ial and the potential efficacy of Aganocide(R) compounds are forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995. The forward- looking statements reflect the views of the management of NovaBay and Alcon as of the date of this press release with respect t...

Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)

... Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995 (the "Act"). When used in this press release, the words "estimate," "project," "anticipate," "expect," "intend," "believe," and similar expres...

deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia

...ation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events...

Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder

...rmore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform act of 1995 permits this discussion. Contacts: Media: Investor Relations: Candace Steele Chip M...

Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia

...ss of $500m. The hormone vasopressin is involved in the regulation of the body's water content and as a vasopressin agonist VA106483 has been shown to act as an anti-diuretic. Contact details: Vantia Therapeutics Dr Jim Phillips, CEO, +44(0)238-076-3433 info@vantia.com , +44(0)7515-3...